Accel targets European AI and defence with $800m fund

US venture capital firm Accel has closed an $800m early-stage fund targeting Europe and Israel. The vehicle marks an increase from the $650m the firm raised for its eighth European early-stage fund just two years ago.

The early-stage pool is accompanied by an additional $2.7bn secured for three other funds. This capital deployment capacity underscores the growing divergence between deep-pocketed US firms and local European venture competitors in the battle for top-tier start-up equity.

Accel is directing this fresh capital toward the continent’s most capital-intensive emerging sectors: artificial intelligence and defence. Recent deployments include Swedish vibe coding startup Lovable, German AI agents company N8n, British air defence manufacturer Cambridge Aerospace, and Swedish legal technology group Legora.

For market participants, the larger fund size signals that US mega-funds continue to view European tech as a prime hunting ground. By increasing its early-stage allocation compared to its previous fund, Accel is positioning itself to write larger initial cheques to secure stakes in competitive rounds.

Accel has operated in Europe for over 25 years, building a portfolio of roughly 250 companies. Its historical bets on major regional winners include Romanian software group UiPath, UK digital bank Monzo, and French health platform Doctolib.

The firm argues the regional market has matured past the point of building purely local services. Europe’s tech ecosystem “has evolved dramatically,” Harry Nelis, a partner at Accel, said. “Today, that momentum is accelerating, with exceptional companies emerging across the region and increasingly building for global markets from the start.”

Artificial intelligence remains the primary driver of this global ambition. “AI is the most transformative technology we have ever seen, opening up new areas for innovation and compressing the time it takes to go from an idea to a scaled business,” Nelis added. For limited partners, this compressed timeline promises faster capital turnover, provided the underlying technology can sustain its current commercial trajectory.